Non-alcoholic steatohepatitis is associated with diabetic cardiomyopathy in type 2 diabetes

被引：0
|
作者：
Cho, D. -H. [1 ]
Chung, J. -O. [1 ]
Chung, D. -J. [1 ]
机构：
[1] Chonnam Natl Univ Hosp, Div Endocrinol & Metab, Gwangju, South Korea
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
937
引用
下载
收藏
页码：S446 / S446
页数：1
相关论文
共 50 条
  • [31] Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes
    Lembo, Erminia
    Russo, Maria Francesca
    Verrastro, Ornella
    Anello, Danila
    Angelini, Giulia
    Iaconelli, Amerigo
    Guidone, Caterina
    Stefanizzi, Gianluigi
    Ciccoritti, Luigi
    Greco, Francesco
    Sessa, Luca
    Riccardi, Laura
    Pompili, Maurizio
    Raffaelli, Marco
    Vecchio, Fabio Maria
    Bornstein, Stefan R.
    Mingrone, Geltrude
    Gastaldelli, Amalia
    Capristo, Esmeralda
    DIABETES & METABOLISM, 2022, 48 (05)
  • [32] Insulin resistance and neurodegeneration: Roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis
    de la Monte, Suzanne M.
    Longato, Lisa
    Tong, Ming
    Wands, Jack R.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1049 - 1060
  • [33] Non-alcoholic steatohepatitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 379 - 379
  • [34] Non-alcoholic steatohepatitis is frequent in young patients with diabetes
    Mueller, Jessica L.
    Corey, Kathleen E.
    Chung, Raymond T.
    Misdraji, Joseph
    Gelrud, Louis G.
    HEPATOLOGY, 2012, 56 : 906A - 906A
  • [35] Non-alcoholic Steatohepatitis (NASH) and alcoholic Steatohepatitis (ASH)
    Roeb, Elke
    DRUG RESEARCH, 2021, 71 : S16 - S18
  • [36] Non-alcoholic fatty liver disease is associated with the prevalence of diabetic retinopathy and diabetic kidney disease in type 2 diabetes mellitus
    Wen, Xin
    Zhou, Xianghai
    Chen, Da
    Cheng, Jiayu
    Zhang, Fuhong
    Li, Xiaolei
    Sun, Jie
    Kong, Lingkun
    Ji, Linong
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [37] Treatment of alcoholic and non-alcoholic steatohepatitis
    Stremmel, W
    Blechacz, B
    Herrmann, T
    Rost, D
    Mueller, S
    INTERNIST, 2001, 42 (12): : 1641 - +
  • [38] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [39] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    Diabetology & Metabolic Syndrome, 13
  • [40] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
12345